Platelet activation and its patient-specific consequences

Thrombosis Research

Volumn 122, Issue 4, 2008, Pages 435-441

  Smyth, Susan S ^a   Monroe III, Dougald M ^b   Wysokinski, Waldemar E ^c   McBane II, Robert D ^c   Whiteheart, Sidney W ^d   Becker, Richard C ^e   Steinhubl, Steven R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Activation; Hemostasis; Platelets; Thrombosis

Indexed keywords

PROCOAGULANT;

ARTERY THROMBOSIS; BLOOD CLOTTING; BLOOD GROUP; CELL; CELL INTERACTION; DISEASE MODEL; ENVIRONMENT; HUMAN; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; THEORY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; ENVIRONMENT; HUMANS; LYMPHOCYTES; MODELS, BIOLOGICAL; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; SWINE; THROMBIN; THROMBOSIS; TIME FACTORS;

EID: 48049087238     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.08.023     Document Type: Review

References (29)

1. Alpert J.S. Myocardial infarction with angiographically normal coronary arteries. Arch Intern Med 154 (1994) 265-269
2. Zimmerman F.H., Cameron A., Fisher L.D., and Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 26 (1995) 654-661
3. Witt B.J., Brown Jr. R.D., Jacobsen S.J., Weston S.A., Yawn B.P., and Roger V.L. A community-based study of stroke after myocardial infarction. Ann Intern Med 143 (2005) 785-792
4. Yee D.L., Sun C.W., Bergeron A.L., Dong J., and Bray P.F. Aggregometry detects platelet hyperactivity in healthy individuals. Blood 15 (2005) 2723-2729
5. Yee D.L., Bergeron A.L., Sun C.W., Dong J.F., and Bray P.F. Platelet hyperreactivity generalizes to multiple forms of stimulation. J Thromb Haemost 4 (2006) 2043-2050
6. Sudo T., Ito H., and Kimura Y. Genetic strain differences in platelet aggregation of laboratory mice. Thromb Haemost 95 (2006) 159-165
7. Allen G.A., Wolberg A.S., Oliver J.A., Hoffman M., Roberts H.R., and Monroe D.M. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2 (2004) 402-413
8. Kempton C.L., Hoffman M., Roberts H.R., and Monroe D.M. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations. Arterioscler Thromb Vasc Biol 25 (2005) 861-866
9. Sumner W.T., Monroe D.M., and Hoffman M. Variability in platelet procoagulant activity in healthy volunteers. Thromb Res 81 (1996) 533-543
10. Oliver J.A., Monroe D.M., Roberts H.R., and Hoffman M. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 19 (1999) 170-177
11. Bevers E.M., Rosing J., and Zwaal R.F. Membrane phospholipids are the major determinant of the binding site for factor X activating- and prothrombinase complexes at the surface of human platelets. Agents Actions Suppl 20 (1986) 69-75
12. Alberio L., Safa O., Clemetson K.J., Esmon C.T., and Dale G.L. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 95 (2000) 1694-1702
13. Heemskerk J.W., Vuist W.M., Feijge M.A., Reutelingsperger C.P., and Lindhout T. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses. Blood 90 (1997) 2615-2625
14. Hemker H.C., Giesen P.L., Ramjee M., Wagenvoord R., and Beguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 83 (2000) 589-591
15. Van Schoonbeek K., Feijge M.A., Van Kampen R.J., Kenis H., Hemker H.C., Giesen P.L., et al. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2 (2004) 476-484
16. Brummel-Ziedins K.E., Pouliot R.L., and Mann K.G. Thrombin generation: phenotypic quantitation. J Thromb Haemost 2 (2004) 281-288
17. Gawaz M., Langer H., and May A.E. Platelets in inflammation and atherogenesis. J Clin Invest 115 (2005) 3378-3384
18. Hrachovinova I., Cambien B., Hafezi-Moghadam A., Kappelmayer J., Camphausen R.T., Widom A., et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 9 (2003) 1020-1025
19. Sullivan V.V., Hawley E.E., Farris D.M., Knipp B.S., Varga A.J., Wrobleski S.K., et al. Decrease in fibrin content of venous thrombi in selectin-deficient mice. J Surg Res 109 (2003) 1-7
20. Yokoyama S., Ikeda H., Haramaki N., Yasukawa H., Murohara T., and Imaizumi T. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates. J Am Coll Cardiol 45 (2005) 1280-1286
21. Ridker P.M., Buring J.E., and Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 103 (2001) 491-495
22. Marcus A.J., and Safier L.B. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 7 (1993) 516-522
23. Goel M.S., and Diamond S.L. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets. J Biol Chem 278 (2003) 9458-9463
24. Goel M.S., and Diamond S.L. Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and -independent mechanisms. Arterioscler Thromb Vasc Biol 21 (2001) 2093-2098
25. McBane R.D., Wysokinski W.E., Chesebro J.H., and Owen W.G. Antithrombotic action of endogenous porcine protein C activated with a latent porcine thrombin preparation. Thromb Haemost 74 (1995) 879-885
26. Wysokinski W.E., McBane II R.D., and Owen W.G. Individual propensity for arterial thrombosis. Arterioscler Thromb Vasc Biol 19 (1999) 883-886
27. Karnicki K., Owen W.G., Miller R.S., and McBane II R.D. Factors contributing to individual propensity for arterial thrombosis. Arterioscler Thromb Vasc Biol 22 (2002) 1495-1499
28. Burches B., Karnicki K., Wysokinski W., and McBane II R.D. Immunohistochemistry of thrombi following iliac venous stenting: a novel model of venous thrombosis. Thromb Haemost 96 5 (2006) 618-622
29. Grau A.J., Boddy A.W., Dukovic D.A., Buggle F., Lichy C., Brandt T., Hacke W., et al., for the CAPRIE Investigators. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 35 (2004) 1147-1152